Evidence map›Paper›PMID 38352761›Full record

ArticleHeliyon2024

Population pharmacokinetic approach to guide personalized sertraline treatment in Chinese patients.

Zi Zhang, Zhihao Guo, Yaqian Tan, Lu Li, Zhanzhang Wang, Yuguan Wen, Shanqing Huang, Dewei Shang

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zi ZhangDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Zhihao GuoDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Yaqian TanDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Lu LiDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Zhanzhang WangDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Yuguan WenDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Shanqing HuangDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Dewei ShangDepartment of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, 510000, China.
Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentsAgeDiscontinue the drugPopulation pharmacokineticSertraline

Identifiers

PMID38352761
PMCPMC10861969
OpenAlexW4391430081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.